Senior Director, US New Product Planning (ADPKD Lead)

Vertex Inc.•Boston, MA

6d•$228,000 - $342,000•Hybrid

About The Position

We are seeking a Senior Director, US New Product Planning to help shape the future of our pipeline and build the foundation for successful US launches within an expanding and highly visible Business Unit. This is a high-impact leadership role for a strategic, commercially minded, and pragmatic leader who thrives at the intersection of asset strategy, US market planning, launch readiness, and Business Unit build-out. This role is ideal for someone who has worked in both the US business and on global teams, and who understands what it takes to succeed in the US market across functions—not just within a single discipline. The individual will represent the US perspective for early pipeline assets, including assets approximately 3-4 years from launch, and help ensure that strategic decisions made today translate into successful launches tomorrow. Importantly, this role offers the opportunity to help build and expand a new Business Unit for the organization. As the pipeline advances, this leader will help define the commercial foundation, capability needs, operating model, resourcing approach, and organizational priorities required to bring new assets into an expanding, strategically important, and highly visible BU.

Requirements

Significant experience in biotech or pharmaceutical commercial strategy, new product planning, marketing, launch strategy, or related roles
Meaningful experience in both US commercial/business roles and Global or enterprise asset/team roles
Demonstrated success in new product planning, pre-launch strategy, or launch planning
Deep experience in hematology and/or rare disease
Strong understanding of US commercialization in complex specialty markets, and related access, site-of-care, and reimbursement considerations
Proven ability to help build or scale commercial infrastructure for new assets entering an expanding Business Unit
Experience building or shaping resourcing plans, operating models, and capability roadmaps
Proven ability to influence senior stakeholders and lead through a matrixed environment
Strong track record of cross-functional collaboration across commercial, medical, market access, analytics, operations, finance, and patient services

Nice To Haves

Experience in US commercial planning, brand leadership, or business leadership
Experience serving on a global asset team or in a global commercial strategy role
Experience in hematology, specialty markets, and complex launch environments
Experience supporting assets from development through launch readiness
Experience helping establish or expand a new or emerging Business Unit, franchise, or therapeutic area organization

Responsibilities

Represent the US commercial perspective on global asset teams for early pipeline assets, especially those approximately 4 years from launch
Lead development of US commercial strategy in partnership with global commercial, medical, market access, HEOR, analytics, operations, and finance
Translate asset strategy into a clear US launch blueprint, including: market development priorities, launch scenarios and key assumptions, capability requirements, organization design implications, field force and non-personal promotion considerations, budget and investment needs
Identify and frame key strategic choices related to: positioning, patient finding and market development, access and reimbursement readiness, evidence generation priorities, customer engagement model, patient services and support strategy
Develop milestone-based and scenario-based plans that prepare the organization for launch well before traditional pre-launch planning begins
Partner with cross-functional leaders to define the capabilities, talent, processes, and infrastructure needed for launch success
Help shape the Business Unit growth strategy by defining what is needed to successfully absorb and commercialize new assets within an expanding BU
Provide strategic input on US commercialization models, including implications for specialty, and institution-based markets
Support governance and executive decision-making with clear recommendations, tradeoffs, and risk assessments
Help ensure a smooth transition from early planning into launch readiness and in-market execution
Help define the strategic and organizational foundations of a growing, high-profile Business Unit